Phibro Animal Health PAHC
NASDAQ PAHC
$39.88 +0.63 (+1.62%)
As of: Oct 22, 2026 · 10:34 AM EDT

Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026)

Updated

Phibro Animal Health (PAHC) reported Income from Continuing Operations of $21.71 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 26.0% from $17.22 million a year earlier but down 9.6% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Phibro Animal Health posted Income from Continuing Operations of $99.72 million, up 106.6% from FY2025.

  • Income from Continuing Operations has a five-year compound annual growth rate of 12.9% (FY2021 to FY2026).
  • By fiscal year, Income from Continuing Operations came in at $48.26 million in FY2025, $2.42 million in FY2024 (-92.6%), $32.61 million in FY2023 (-33.7%) and $49.18 million in FY2022 (-9.6%).
  • Five-year quarterly Income from Continuing Operations spans a low of -$8.02 million in fiscal Q1 2024 and a high of $27.46 million in fiscal Q2 2026.
  • Year over year, Income from Continuing Operations has now increased in each of the last four quarters, with growth averaging 230.3% over the last six quarters.
  • The high point for year-over-year Income from Continuing Operations in five years was fiscal Q2 2026 (growth of 762.1%); the low point was fiscal Q4 2024 (a decline of 93.5%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $24.02 million (Q3 2026), $27.46 million (Q2 2026) and $26.53 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn 5.53 Bn
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn 3.62 Bn
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn 2.51 Bn
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn -10.50 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -246.00 Mn
10 Phibro Animal Health 1.62 Bn 1.30 Bn 134.40 Mn 21.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.71 Mn
Mar 31, 2026 24.02 Mn
Dec 31, 2025 27.46 Mn
Sep 30, 2025 26.53 Mn
Jun 30, 2025 17.22 Mn
Mar 31, 2025 20.88 Mn
Dec 31, 2024 3.19 Mn
Sep 30, 2024 6.98 Mn
Jun 30, 2024 752,000.00
Mar 31, 2024 8.41 Mn
Dec 31, 2023 1.27 Mn
Sep 30, 2023 -8.02 Mn
Jun 30, 2023 11.50 Mn
Mar 31, 2023 10.04 Mn
Dec 31, 2022 7.21 Mn
Sep 30, 2022 3.86 Mn
Jun 30, 2022 7.49 Mn
Mar 31, 2022 17.69 Mn
Dec 31, 2021 17.47 Mn
Sep 30, 2021 6.53 Mn
API Access

Phibro Animal Health Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PAHC&period=max&api_key=YOUR_API_KEY